Today, a Director at Luminex (NASDAQ: LMNX), Walter Loewenbaum, sold shares of LMNX for $820K.
Following Walter Loewenbaum’s last LMNX Sell transaction on November 17, 2017, the stock climbed by 5.8%. In addition to Walter Loewenbaum, 3 other LMNX executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Luminex’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $82.66 million and quarterly net profit of $13.19 million. In comparison, last year the company earned revenue of $77.78 million and had a net profit of $9.06 million. LMNX’s market cap is $1.19B and the company has a P/E ratio of 35.93. Currently, Luminex has an average volume of 32.21K.
Four different firms, including Cowen & Co. and Deutsche Bank, currently also have a Sell rating on the stock.
In the last 30 days, insiders have sold $940.1K worth of LMNX shares and purchased $104.2K worth of LMNX shares. The insider sentiment on Luminex has been negative according to 32 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Walter Loewenbaum’s trades have generated a -19.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.
